A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Summary

The purpose of this study is to determine whether AZD7624 can reduce acute Chronic Obstructive Pulmonary Disease (COPD) exacerbations in patients on COPD maintenance therapy with a history of frequent acute exacerbations.

Timeline

Start

2014-10-28

Primary completion

2016-04-04

Completion

2016-04-04

Outcome

Missed primary endpoint

registry AZD7624 vs Placebo; p = 0.2371; Hazard Ratio (HR) 1.39 (95% CI 0.81 to 2.40); Regression, Cox NCT02238483 ↗

Drugs

Indications